Simultaneous Prescribing of Atypical Antipsychotics, Conventional Antipsychotics and Anticholinergics-a European Study

Overview

Journal Pharm World Sci

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2007 Mar 3

PMID 17333501

Citations 22

Authors

W J Broekema

I W de Groot

P N van Harten

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to investigate to what extent atypical antipsychotics, conventional antipsychotics and anticholinergics are prescribed simultaneously in daily clinical practice in Europe.

Method: A pharmaco-epidemiological study was carried out in which hospital pharmacists from 45 hospitals in Belgium, Denmark, France, Germany, The Netherlands and Scotland participated. Prescription data for 2,725 patients (mainly inpatients) who had been using an atypical antipsychotic for more than 6 weeks were analysed.

Main Outcome Measure: The frequencies of simultaneous prescription of atypical antipsychotics with other antipsychotics and/or anticholinergics.

Results: In this sample of patients with an atypical antipsychotic 42.1% was prescribed another antipsychotic (24.1% if low-potent antipsychotics were not included in the analysis) and 30.1% was prescribed an anticholinergic. In total 47.1% of patients were prescribed an atypical antipsychotic without any other antipsychotic or anticholinergic.

Conclusion: It is common practice to prescribe a combination of atypical antipsychotics and conventional antipsychotics and/or anticholinergics. This suggests that monotherapy involving an atypical antipsychotic is not considered to be an adequate treatment for a substantial number of patients in clinical practice.

Citing Articles

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics.

Hori H, Yasui-Furukori N, Hasegawa N, Iga J, Ochi S, Ichihashi K Front Psychiatry. 2022; 13:823826.

PMID: 35656353 PMC: 9152135. DOI: 10.3389/fpsyt.2022.823826.

Anticholinergic Burden and Cognitive Performance in Patients With Schizophrenia: A Systematic Literature Review.

Georgiou R, Lamnisos D, Giannakou K Front Psychiatry. 2022; 12:779607.

PMID: 35027893 PMC: 8748260. DOI: 10.3389/fpsyt.2021.779607.

Psychotropic drug prescribing in a Nigerian psychiatric hospital.

Agbonile I, Famuyiwa O Int Psychiatry. 2019; 6(4):96-98.

PMID: 31508010 PMC: 6734891.

Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.

Brostedt E, Msghina M, Persson M, Wettermark B BMC Psychiatry. 2017; 17(1):416.

PMID: 29284436 PMC: 5747108. DOI: 10.1186/s12888-017-1582-x.

Cytochrome P450-mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy.

Paulzen M, Haen E, Hiemke C, Stegmann B, Lammertz S, Grunder G Br J Clin Pharmacol. 2017; 83(8):1668-1675.

PMID: 28160505 PMC: 5510064. DOI: 10.1111/bcp.13255.

References

Stahl S . Antipsychotic polypharmacy, Part 1: Therapeutic option or dirty little secret?. J Clin Psychiatry. 1999; 60(7):425-6. DOI: 10.4088/jcp.v60n0701. View

Geddes J, Freemantle N, Harrison P, Bebbington P . Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000; 321(7273):1371-6. PMC: 27538. DOI: 10.1136/bmj.321.7273.1371. View

Procyshyn R, Kennedy N, Tse G, Thompson B . Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Can J Psychiatry. 2001; 46(4):334-9. DOI: 10.1177/070674370104600404. View

Freudenreich O, Goff D . Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand. 2002; 106(5):323-30. DOI: 10.1034/j.1600-0447.2002.01331.x. View

Tapp A, Wood A, Secrest L, Erdmann J, Cubberley L, Kilzieh N . Combination antipsychotic therapy in clinical practice. Psychiatr Serv. 2003; 54(1):55-9. DOI: 10.1176/appi.ps.54.1.55. View

Jaffe A, Levine J . Antipsychotic medication coprescribing in a large state hospital system. Pharmacoepidemiol Drug Saf. 2003; 12(1):41-8. DOI: 10.1002/pds.783. View

Paton C, Lelliott P, Harrington M, Okocha C, Sensky T, Duffett R . Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol. 2003; 17(2):223-9. DOI: 10.1177/0269881103017002012. View

Naber D, Holzbach R, Perro C, Hippius H . Clinical management of clozapine patients in relation to efficacy and side-effects. Br J Psychiatry Suppl. 1992; (17):54-9. View

Minzenberg M, Poole J, Benton C, Vinogradov S . Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry. 2004; 161(1):116-24. DOI: 10.1176/appi.ajp.161.1.116. View

10.

Grohmann R, Engel R, Geissler K, Ruther E . Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry. 2004; 37 Suppl 1:S27-38. DOI: 10.1055/s-2004-815508. View

11.

Centorrino F, Goren J, Hennen J, Salvatore P, Kelleher J, Baldessarini R . Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004; 161(4):700-6. DOI: 10.1176/appi.ajp.161.4.700. View

12.

Taylor Shubhra Mace Shameem Mir Robert Kerwin D . A prescription survey of the use of atypical antipsychotics for hospital inpatients in the United Kingdom. Int J Psychiatry Clin Pract. 2014; 4(1):41-6. DOI: 10.1080/13651500052048749. View

13.

Schulz P, Rey M, Dick P, Tissot R . Guidelines for the dosage of neuroleptics. II: Changing from daily oral to long acting injectable neuroleptics. Int Clin Psychopharmacol. 1989; 4(2):105-14. DOI: 10.1097/00004850-198904000-00002. View

14.

Juul Povlsen U, Noring U, Fog R, Gerlach J . Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand. 1985; 71(2):176-85. DOI: 10.1111/j.1600-0447.1985.tb01268.x. View

15.

Peacock L, Gerlach J . Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry. 1994; 55(2):44-9. View

16.

Waddington J, Youssef H, Kinsella A . Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry. 1999; 173:325-9. DOI: 10.1192/bjp.173.4.325. View